Literature DB >> 27742735

β-Lactamases: A Focus on Current Challenges.

Robert A Bonomo1,2.   

Abstract

β-Lactamases, the enzymes that hydrolyze β-lactam antibiotics, remain the greatest threat to the usage of these agents. In this review, the mechanism of hydrolysis is discussed for both those enzymes that use serine at the active site and those that require divalent zinc ions for hydrolysis. The β-lactamases now include >2000 unique, naturally occurring amino acid sequences. Some of the clinically most important of these are the class A penicillinases, the extended-spectrum β-lactamases (ESBLs), the AmpC cephalosporinases, and the carbapenem-hydrolyzing enzymes in both the serine and metalloenzyme groups. Because of the versatility of these enzymes to evolve as new β-lactams are used therapeutically, new approaches to antimicrobial therapy may be required.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27742735      PMCID: PMC5204326          DOI: 10.1101/cshperspect.a025239

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  61 in total

1.  Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.

Authors:  Meha P Patel; Liya Hu; Cameron A Brown; Zhizeng Sun; Carolyn J Adamski; Vlatko Stojanoski; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

2.  Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.

Authors:  Jordi Rello; Cristina Sarda; Djamel Mokart; Kostoula Arvaniti; Murat Akova; Alexis Tabah; Elie Azoulay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

3.  In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem.

Authors:  Nicole Cotroneo; Aileen Rubio; Ian A Critchley; Chris Pillar; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

4.  Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Authors:  Allie Y Chen; Pei W Thomas; Zishuo Cheng; Nasa Y Xu; David L Tierney; Michael W Crowder; Walter Fast; Seth M Cohen
Journal:  ChemMedChem       Date:  2019-05-24       Impact factor: 3.466

Review 5.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

Review 6.  Structural basis for the coordination of cell division with the synthesis of the bacterial cell envelope.

Authors:  Simon Booth; Richard J Lewis
Journal:  Protein Sci       Date:  2019-09-30       Impact factor: 6.725

Review 7.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

8.  Unravelling the antibiotic and heavy metal resistome of a chronically polluted soil.

Authors:  Lateef Babatunde Salam
Journal:  3 Biotech       Date:  2020-05-07       Impact factor: 2.406

Review 9.  Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms.

Authors:  Audrey N Schuetz; Sergio Reyes; Pranita D Tamma
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

Review 10.  Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.

Authors:  Felipe Francisco Tuon; Jaime L Rocha; Marcelo R Formigoni-Pinto
Journal:  Infection       Date:  2017-11-07       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.